Pivadga C, Odum EP, Hart BAA-. Hydroxyurea Dose Escalation to Maximum Tolerated Dose in Pediatric Sickle Cell Disease: Hematologic and Clinical Outcomes in a Resource-Limited Setting in Cameroon. A Quasi-Experimental Study. SJHR-Africa [Internet]. 2026 Mar. 30 [cited 2026 Sep. 10];7(3):10. Available from: https://sjhrafrica.org.sjhresearchafrica.org/index.php/public-html/article/view/2851